Flurpiridaz

CHEMBL494622 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
368.8 g/mol
LogP
3.0
Phase
4

This is a radioactive imaging agent used with PET scanning to evaluate blood flow to the heart muscle. It helps doctors detect coronary artery disease and identify areas of the heart that may not be receiving enough blood. The medication is administered by injection before the scan and is not a treatment drug.

Molecular Weight

368.8000 g/mol

LogP

3.00

TPSA

51.10 Ų

Lipinski RO5

Pass

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)(C)n1ncc(OCc2ccc(COCCF)cc2)c(Cl)c1=O

InChI

InChI=1S/C18H22ClFN2O3/c1-18(2,3)22-17(23)16(19)15(10-21-22)25-12-14-6-4-13(5-7-14)11-24-9-8-20/h4-7,10H,8-9,11-12H2,1-3H3

Molecular Formula

C18H22ClFN2O3

HBD / HBA

- / 5

Rotatable Bonds

8

Heavy Atoms

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This is a radioactive imaging agent used with PET scanning to evaluate blood flow to the heart muscle. It helps doctors detect coronary artery disease and identify areas of the heart that may not be receiving enough blood. The medication is administered by injection before the scan and is not a treatment drug.

Yes, Flurpiridaz is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL494622. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24864646. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.